SCHEMBL13744783

SCHEMBL13744783

Nc1c(C(=O)Cc2ccccc2)oc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.60
NPC1 O15118 7/20 0.60
KMT2A Q03164 3/20 0.60
TDP1 Q9NUW8 2/20 0.58
KDM4E B2RXH2 8/20 0.58
AHR P35869 2/20 0.55
SMN1; SMN2 Q16637 6/20 0.51
RAB9A P51151 5/20 0.51
POLB P06746 2/20 0.51
HPGD P15428 4/20 0.48
PKM P14618 1/20 0.48
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 2/20 0.48
USP2 O75604 2/20 0.48
HCRTR1 O43613 1/20 0.48
TSHR P16473 1/20 0.48
CASP1 P29466 1/20 0.48
NFKB1 P19838 1/20 0.48
HTT P42858 1/20 0.48
NFKB2 Q00653 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664957 0.81 KDM4E (0.66) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL1006030 0.80 MAPT (0.67) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL2774740 0.80 MAPT (0.72) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL13744123 0.76 TSHR (0.65) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL429754 0.76 MAPT (1.00) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL30168106 0.75 KDM4E (0.68) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL6857835 0.75 KDM4E (0.68) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL7560962 0.75 KDM4E (0.65) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL13743910 0.72 NPC1 (0.79) MAPTNPC1KMT2ATDP1KDM4E
SCHEMBL1885241 0.71 KDM4E (1.00) MAPTNPC1KMT2ATDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 MAPT 4681/4885NPC1 3431/4885KMT2A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.